Michael Berelowitz, Director at ORAMED PHARMACEUTICALS INC. (ORMP), sold 9,434 shares at $10.50 ($99K) on 2014-03-31, disclosed to the SEC on 2014-04-02.
Open-market sale of $99k ORMP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ORMP | SELL | 2015-12-09 | $11K | — | Filing → |